1251 – 1260 of 1344
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event.
(
- Contribution to journal › Article
-
Mark
High-titer GAD65 autoantibodies detected in adult diabetes patients using a high efficiency expression vector and cold GAD65 displacement.
(
- Contribution to journal › Article
-
Mark
Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation.
(
- Contribution to journal › Article
-
Mark
B-lymphocyte commitment: Identifying the point of no return.
(
- Contribution to journal › Article
-
Mark
Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment.
(
- Contribution to journal › Letter
-
Mark
Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder
(
- Contribution to journal › Article
-
Mark
Early Cellular Pathways of Mouse Natural Killer Cell Development.
(
- Contribution to journal › Scientific review
-
Mark
Defining the hematopoietic stem cell niche: the chicken and the egg conundrum
(
- Contribution to journal › Scientific review
-
Mark
Stress hematopoiesis requires Erg
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation
(
- Contribution to journal › Article